Antisense nucleic acids targeted to the thymidylate synthase (TS) mrna translation start site stimulate ts gene transcription

Experimental Cell Research

Volumn 243, Issue 1, 1998, Pages 11-21

  DeMoor, Janice M ^a   Vincent, Mark D ^a,b   Collins, Olga M ^a   Koropatnick, James ^a,b  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Antisense RNA; Oligodeoxynucleotides; Run on transcription; Thymidylate synthase

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; NUCLEIC ACID; THYMIDYLATE SYNTHASE;

ARTICLE; BASE PAIRING; BINDING SITE; ENZYME BINDING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RNA SEQUENCE; RNA TRANSLATION; TRANSCRIPTION REGULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0032566274     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4059     Document Type: Article

References (62)

1. Danenberg, P. V. (1977). Thymidylate synthase: A target enzyme in cancer chemotherapy. Biochim. Biophys. Acta 473, 73-92.
2. Maley, F., and Maley, G. F. (1960). Nucleotide interconversions. II. Elevation of deoxycytidylate deaminase and thymidylate synthetase in regenerating rat liver. J. Biol. Chem. 235, 2968-2970.
3. Lochshin, A., Moran, R. G., and Danenberg, P. V. (1979). Thymidylate synthetase purified to homogeneity from human leu- kemic cells. Proc. Natl. Acad. Sci. USA 76, 750-754.
4. Farnham, P. J., Slansky, J. E., and Kollmar, R. (1993). The role of E2F in the mammalian cell cycle. Biochim. Biophys. Acta Rev. Cancer 1155, 125-131.
5. Mudrak, I., Ogris, E., Rogheneder, H., and Wintersberger, E. (1994). Co-ordinated trans activation of DNA synthesis- and precursor-producing enzymes by polyomavirus large T antigen through interaction with the retinoblastoma protein. Mol. Cell. Biol. 14, 1886-1892.
6. 1/S-regulatory genes. Mol. Cell. Biol. 15, 4215-4224.
7. Navalgund, L. G., Rossana, C., Muench, A. J., and Johnson, L. F. (1980). Cell cycle regulation of thymidylate synthetase gene expression in cultured mouse fibroblasts. J. Biol. Chem. 255, 7386-7390.
8. Ayusawa, D., Shimizu, K., Koyama, H., Kaneda, S., Takeishi, K., and Seno, T. (1986). Cell-cycle-directed regulation of thymidylate synthase messenger RNA in human diploid fibroblasts stimulated to proliferate. J. Mol. Biol. 190, 559-567.
9. Jenh, C.-H., Geyer, P. K., and Johnson, L. F. (1985). Control of thymidylate synthase mRNA content and gene transcription in an overproducing mouse cell line. Mol. Cell. Biol. 5, 2527-2532.
10. Johnson, L. F. (1994). Posttranscriptional regulation of thymidylate synthase gene expression. J. Cell. Biochem. 54, 387-392.
11. Chu, E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C., Zinn, S., and Allegra, C. J. (1991). Auto- regulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc. Natl. Acad. Sci. USA 88, 8977-8981.
12. Chu, E., Voeller, D., Koeller, D. M., Drake, J. C., Takimoto, C. H., Maley, G. F., Maley, F., and Allegra, C. J. (1993). Identification of an RNA binding site for human thymidylate synthase. Proc. Natl. Acad. Sci. USA 90, 517-521.
13. Chu, E., Voeller, D. M., Jones, K. L., Takechi, T., Maley, G. F., Maley, F., Segal, S., and Allegra, C. J. (1994). Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells. Mol. Cell. Biol. 14, 207-213.
14. Voeller, D. M., Changchien, L.-M., Maley, G. F., Maley, F., Takechi, T., Turner, R. E., Montfort, W. R., Allegra, C. J., and Chu, E. (1995). Characterisation of a specific interaction between Escherichia coli thymidylate synthase and Escherichia coli thymidylate synthase mRNA. Nucleic Acids Res. 23, 869-875.
15. Chu, E., Takechi, T., Jones, K. L., Voeller, D. M., Copur, S. M., Maley, G. F., Maley, F., Segal, S., and Allegra, C. J. (1995). Thymidylate synthase binds to c-myc RNA in human colon cancer cells and in vitro. Mol. Cell. Biol. 15, 179-185.
16. Hardy, L. W., Finer-Moore, J. S., Montfort, W. R., Jones, M. O., Santi, D. V., and Stroud, R. M. (1987). Atomic structure of thymidylate synthase: target for rational drug design. Science 235, 448-455.
17. Suzuki, M., Ohwada, M., Tamada, T., and Tsuru, S. (1994). Thymidylate synthase as a prognostic factor in ovarian cancer. Oncology 51, 334-338.
18. Johnston, P. G., Fisher, E. R., Rockette, H. E., Fisher, B., Wolmark, N., Drake, J. C., Chabner, B. A., and Allegra, C. J. (1994). The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J. Clin. Oncol. 12, 2640-2647.
19. Volm, M., Zintl, F., and Sauerbrey, A. (1994). Thymidylate synthase in childhood acute non-lymphoblastic leukemia. Anticancer Res. 14, 1271-1276.
20. Volm, M., and Mattern, J. (1992). Elevated expression of thymidylate synthase in doxorubicin resistant human non-small cell lung carcinomas. Anticancer Res. 12, 2293-2296.
21. Peters, G. J., Laurensse, E., Leyva, A., Lankelma, J., and Pinedo, H. M. (1986). Sensitivity of human, murine and rat cells to 5-fluorouracil and 5′-deoxy-5-fluorouridine in relation to drug-metabolising enzymes. Cancer Res. 46, 20-28.
22. Peters, G. J., van der Wilt, C. L., and van Groeningen, C. J. (1994). Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase. Eur. J. Cancer 30A, 1408-1411.
23. Heidelberger, C., Danenberg, P. V., and Moran, R. G. (1983). Fluorinated pyrimidines and their nucleosides. Adv. Enzymol. 54, 58-119.
24. Calvert, A. H., Alison, D. L., Harland, S. J., Robinson, B. A., Jackman, A. L., Jones, T. R., Newell, D. R., Siddik, Z. H., Wiltshaw, E., McElwain, T. J., Smith, I. E., and Harrap, K. R. (1986). A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N-10-propargyl-5,8-dideazafolic acid, CB3717. J. Clin. Oncol. 4, 1245-1252.
25. Jackman, A. L., Marsham, P. R., Moran, R. G., Kimbell, R., O'Connor, B. M., Hughes, L. R., and Calvert, A. H. (1991). Thymidylate synthase inhibitors: the in vitro activity of a series of heterocyclic benzoyl ring modified 2-desamino-2-methyl-N10- substituted-5,8-dideazafolates. Adv. Enzyme Regul. 31, 13-27.
26. Jackman, A. L., Taylor, G. A., Gibson, W., Kimbell, R., Brown, M., Calvert, A. H., Judson, I. R., and Hughes, L. R. (1991). ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumour cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res. 51, 5579-5586.
27. Keyomarsi, K., Samet, J., Molnar, G., and Pardee, A. B. (1993). The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzyme. J. Biol. Chem. 268, 15142-15149.
28. Chu, E., Zinn, S., Boarman, D., and Allegra, C. J. (1990). Interaction of γ interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Cancer Res. 50, 5834-5840.
29. Chu, E., Koeller, D. M., Johnston, P. G., Zinn, S., and Allegra, C. J. (1993). Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-γ. Mol. Pharmacol. 43, 527-533.
30. Rapaport, E., Misiura, K., Agrawal, S., and Zamecnik, P. (1992). Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparum. Proc. Natl Acad. Sci. USA 89, 8577-8580.
31. Koropatnick, J., DeMoor, J., Vincent, M., and Collins, O. (1997). Discrimination of run-on transcription from constitutive genes and antisense expression vectors in the same cells. BioTechniques 22, 64-66.
32. Takeishi, K, Kaneda, S., Ayusawa, D., Shimizu, K., Gotoh, O., and Seno, T. (1985). Nucleotide sequence of a functional cDNA for human thymidylate synthase. Nucleic Acids Res. 13, 2035-2043.
33. McKay, R. A., Cummins, L. L., Graham, M. J., Lesnik, E. A., Owens, S. R., Winniman, M., and Dean, N. M. (1996). Enhanced activity of an antisense oligonucleotide targeting murine protein kinase Ca by the incorporation of 2′-O-propyl modifications. Nucleic Acids Res. 24, 411-417.
34. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). "Molecular Cloning: A Laboratory Manual," Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
35. Church, G. M., and Gilbert, W. (1984). Genomic sequencing. Proc. Natl. Acad. Sci. USA 81, 1991-1995.
36. Jelinek, W. R., Toomey, T. P., Leinwand, L., Duncan, C. H., Biro, P. H., Choudary, P. V., Weissman, S. M., Rubin, C. M., Houck, C. M., Deininger, P. L., and Schmid, C. W. (1980). Ubiquitous, interspersed repeated sequences in mammalian genomes. Proc. Natl. Acad. Sci. USA 77, 1398-1402.
37. Koropatnick, J., Pearson, J., and Harris, J. F. (1988). Extensive loss of human DNA accompanies loss of antibody production in heteromyeloma hybridoma cells. Mol. Biol. Med. 5, 69-83.
38. Kikuchi, K., Bichell, D. P., and Rotwein, P. (1992). Chromatin changes accompany the developmental activation of insulin- like growth factor I gene transcription. J. Biol. Chem. 267, 21505-21511.
39. Almendral, J. M., Sommer, D., Macdonald Bravo, H., Burckhardt, J., Perera, J., and Bravo, R. (1988). Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol. Cell. Biol. 8, 2140-2148.
40. Marzluff, W. F., and Huang, R. C. C. (1984). Transcription of RNA in isolated nuclei. In "Transcription and Translation: A Practical Approach" (B. D. Hames and S. J. Higgins, Eds.), IRL Press, Oxford.
41. Denhardt, D. T., Greenberg, A. H., Egan, S. E., Hamilton, R. E., and Wright, J. S. (1988). Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H- ras-transformed murine fibroblasts. Oncogene 2, 55-59.
42. Behrend, E. I., Craig, A. M., Wilson, S. M., Denhardt, D. T., and Chambers, A. F. (1994). Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res. 54, 832-837.
43. Koropatnick, J. (1980). Amplification of metallothionein-1 genes in mouse liver cells in situ: Extra copies are transcriptionally active. Proc. Soc. Exp. Biol. Med. 188, 287-300.
44. Karin, M., and Richards, R. I. (1982). Human metallothionein genes: Molecular cloning and sequence analysis of the mRNA. Nucleic Acids Res. 10, 3165-3173.
45. 4PTEGLU assays. Adv. Exp. Med. Biol. 244, 97-104.
46. Leibbrandt, M. E. I., Khokha, R., and Koropatnick, J. (1994). Antisense down-regulation of metallothionein in a human monocytic cell line alters adherence, invasion, and the respiratory burst. Cell. Growth. Differ. 5, 17-25.
47. Kiehntopf, M., Brach, M. A., Licht, T., Petschauer, S., Karawajew, L., Kirschning, C., and Herrmann, F. (1994). Ribozymemediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. EMBO J. 13, 4645-4652.
48. Kobayashi, H., Dorai, T., Holland, J. F., and Ohnuma, T. (1994). Reversal of drug sensitivity in multidrug-resistant tumour cells by an MDR1 (PGY1) ribozyme. Cancer Res. 54, 1271-1275.
49. Mizutani, Y., Fukumoto, M., Bonavida, B., and Yoshida, O. (1994). Enhancement of sensitivity of urinary bladder tumour cells to cisplatin by c-myc antisense oligonucleotide. Cancer, 74, 2546-2554.
50. Maeda, M., Watanabe, N., Okamoto, T., Tsuji, N., and Niitsu, Y. (1994). Endogenous tumour necrosis factor functions as a resistant factor against adriamycin. Int. J. Cancer 58, 376-379.
51. Schlaifer, D., Meyer, K., Muller, C., Attal, M., Smith, M. T., Tamaki, S., Weimels, J., Pris, J., Jaffrézou, J. P., Laurent, G., and Meyers, C. E. (1994). Antisense inhibition of myeloperoxidase increases the sensitivity of the HL-60 line to vincristine. Leukemia 8, 289-291.
52. Gudkov, A. V., Kazarov, A. R., Thimmapaya, R., Axenovich, S. A., Mazo, I. A., and Roninson, I. B. (1994). Cloning mammalian genes by expression selection of genetic suppresser elements: association of kinesin with drug resistance and cell immortalization. Proc. Natl. Acad. Sci. USA 91, 3744-3748.
53. Kitada, S., Takayama, S., De Riel, K., Tanaka, S., and Reed, J. C. (1994). Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. Antisense Res. Dev. 4, 71-79.
54. Marzluff, W. F. (1992). Histone 3′ ends: essential and regulatory functions. Gene Express. 2, 93-97.
55. Ayusawa, D., Takeishi, K., Kaneda, S., Shimizu, K., Koyama, H., and Seno, T. (1984). Isolation of functional cDNA clones for human thymidylate synthase. J. Biol. Chem. 259, 14361-14364.
56. Hawley-Nelson, P., Ciccarone, V., Gebeyehu, G., Jessee, J. and Feigner, P. L. (1993). Lipofectamine reagent: A new, higher efficiency polycationic liposome transfection reagent. Focus 15, 73-79.
57. Horie, N., Nozawa, R., and Takeishi, K. (1992). Identification of cellular differentiation-dependent nuclear factors that bind to a human gene for thymidylate synthase. Biochem. Biophys. Res. Commun. 185, 127-133.
58. Horie, N., Chimoto, M., Nozawa, R., and Takeishi, K. (1993). Characterisation of regulatory sequences and nuclear factors that function in Cupertino with the promoter of the human thymidylate synthase gene. Biochim. Biophys. Acta 1216, 409-416.
59. Li, Y., Slansky, J. E., Myers, D. J., Drinkwater, N. R., Kaelin, W. G., and Farnham, P. J. (1994). Cloning, chromosomal location, and characterisation of mouse E2F1. Mol. Cell. Biol. 14, 1861-1869.
60. Chittenden, T., Livingston, D. M., and DeCaprio, J. A. (1993). Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F. Mol. Cell. Biol. 13, 3975-3983.
61. Mudryj, M., Hiebert, S. W., and Nevins, J. R. (1990). A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J. 9, 2179-2184.
62. Altiok, S., and Groner, B. (1994). β-Casein mRNA sequesters a single-stranded nucleic acid-binding protein which negatively regulates the β-casein gene promoter. Mol. Cell. Biol. 14, 6004-6012.